SNT 6.06% 3.1¢ syntara limited

Ann: Investor presentation, page-11

  1. 5,694 Posts.
    lightbulb Created with Sketch. 673
    Bronchitol poor sales still a major thorn imo

    Operational savings but at what cost to revenue and the milestone of cashflow positive

    Choice of Distributors and perhaps market research failing badly imo

    Or Covid having major effect! even more so than expected

    anyone do some research into that scar treatment ‘competition’ which they would be happy to share


 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
-0.002(6.06%)
Mkt cap ! $37.01M
Open High Low Value Volume
3.2¢ 3.2¢ 3.1¢ $94.1K 2.963M

Buyers (Bids)

No. Vol. Price($)
1 31544 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 300000 1
View Market Depth
Last trade - 16.10pm 05/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.